⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propanol SCHEMBL9352990 | 0.89 | ALDH1A1 (0.37) | — | |
| Ethylene Glycol SCHEMBL8214451 | 0.84 | TSHR (0.30) | — | |
| Alcohol SCHEMBL23291094 | 0.83 | — | — | |
| Ethylene Glycol SCHEMBL27740302 | 0.82 | TSHR (0.50) | — | |
| Ethylene Glycol SCHEMBL2229955 | 0.82 | — | — | |
| Butyl Alcohol SCHEMBL19438991 | 0.82 | ALDH1A1 (0.61) | — | |
| Di(Hydroxyethyl)Ether SCHEMBL392786 | 0.79 | TSHR (0.62) | — | |
| Tetraethylene Glycol SCHEMBL9747717 | 0.77 | MEN1 (0.65) | — | |
| Triethylene Glycol SCHEMBL2830692 | 0.77 | MEN1 (0.65) | — | |
| Ethylene Glycol SCHEMBL15995529 | 0.77 | TSHR (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4535492-A1 | LOCAL HIGH-CONCENTRATION ELECTROLYTE, SECONDARY BATTERY, ELECTRONIC DEVICE, AND MOBILE APPARATUS | Huawei Technologies Co., Ltd. (CN) | 2025-04-09 | — | — | EP | disclosed |
| CN-117438648-A | Local high-concentration electrolyte, secondary battery, electronic device, and mobile device | 华为技术有限公司 | 2024-01-23 | — | — | CN | disclosed |
| WO-2024012244-A1 | LOCAL HIGH-CONCENTRATION ELECTROLYTE, SECONDARY BATTERY, ELECTRONIC DEVICE, AND MOBILE APPARATUS | 华为技术有限公司 | 2024-01-18 | — | — | WO | disclosed |
| CN-114957564-A | Bioactive coating | 生物相互作用有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-20210130552-A1 | REVERSIBLE METALLOPOLYMER NETWORK | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-05-06 | — | — | US | disclosed |
| US-10875970-B2 | Reversible metallopolymer network | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200087463-A1 | REVERSIBLE METALLOPOLYMER NETWORK | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2020-03-19 | — | — | US | disclosed |
| CN-110776610-A | Bioactive coating | 生物相互作用有限公司 | 2020-02-11 | — | — | CN | disclosed |
| CN-105517585-B | Bioactivity coatings | 生物相互作用有限公司 | 2019-11-22 | — | — | CN | disclosed |
| US-20170158824-A1 | REVERSIBLE METALLOPOLYMER NETWORK | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2017-06-08 | — | — | US | disclosed |
| EP-1379525-B1 | HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | NPS PHARMA INC (US) | 2007-10-10 | — | — | EP | disclosed |
| US-7112595-B2 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | NPS PHARMACEUTICALS, INC. (US) | 2006-09-26 | — | — | US | disclosed |
| US-20060189661-A1 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | ASTRAZENECA AB (SE) | 2006-08-24 | — | — | US | disclosed |
| EP-1679313-A2 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | NPS PHARMACEUTICALS, INC. (US) | 2006-07-12 | — | — | EP | disclosed |
| US-20050154027-A1 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | NPS PHARMACEUTICALS, INC. | 2005-07-14 | — | — | US | disclosed |
| EP-1379525-A2 | HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | NPS PHARMACEUTICALS, INC. (US) | 2004-01-14 | — | — | EP | disclosed |
| US-6660753-B2 | For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease | NPS PHARMACEUTICALS, INC. | 2003-12-09 | — | — | US | disclosed |
| US-20030055085-A1 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | ASTRAZENECA AB (SE) | 2003-03-20 | — | — | US | disclosed |
| WO-2002068417-A3 | HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | SLASSI ABDELMALIK (CA) | 2002-11-14 | — | — | WO | disclosed |
| WO-2002068417-A2 | HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | NPS PHARMACEUTICALS, INC. (US) | 2002-09-06 | — | — | WO | disclosed |